Department of Cardiac Surgery, Munich University Medical Center, Munich, Germany
Abstract
Heart failure is one of the leading causes of death worldwide. End stage disease often requires heart transplantation, which is hampered by donor organ shortage. Tissue engineering represents a promising alternative approach for cardiac repair. For the generation of artificial heart muscle tissue several cell types, scaffold materials and bioreactor designs are under investigation. In this review, the use of mesenchymal stem cells derived from human umbilical cord tissue (UCMSC) for cardiac tissue engineering will be discussed.
Hollweck, T. & Eissner, G. (2012). Mesenchymal stem cells from umbilical cord tissue as potentialtherapeutics for cardiomyodegenerative diseases – a review. International Journal of Complementary and Integrative Health, 1(3), 119-132.
MLA
Hollweck, T., & Eissner, G. "Mesenchymal stem cells from umbilical cord tissue as potentialtherapeutics for cardiomyodegenerative diseases – a review", International Journal of Complementary and Integrative Health, 1, 3, 2012, 119-132.
HARVARD
Hollweck T., Eissner G. (2012). 'Mesenchymal stem cells from umbilical cord tissue as potentialtherapeutics for cardiomyodegenerative diseases – a review', International Journal of Complementary and Integrative Health, 1(3), pp. 119-132.
CHICAGO
T. Hollweck & G. Eissner, "Mesenchymal stem cells from umbilical cord tissue as potentialtherapeutics for cardiomyodegenerative diseases – a review," International Journal of Complementary and Integrative Health, 1 3 (2012): 119-132,
VANCOUVER
Hollweck T., Eissner G. Mesenchymal stem cells from umbilical cord tissue as potentialtherapeutics for cardiomyodegenerative diseases – a review. Int J Complement Integr Health. 2012;1(3):119-132.